Welcome Message
Dear Esteemed Participants,
On behalf of the Organizing Committee, it is our great pleasure to welcome you to the 20th World Congress on Endocrinology and Diabetes, scheduled for September 29–30, 2026, in the spectacular city of Paris, France.
This prestigious congress unites endocrinologists, diabetologists, metabolic scientists, clinical researchers, health policymakers, and industry innovators from around the globe. The 2026 edition focuses on groundbreaking scientific discoveries, emerging technologies, and transformative clinical strategies shaping the future of endocrine and metabolic disorders. With diabetes and endocrine conditions continuing to affect millions worldwide, this congress serves as a vital global platform for knowledge exchange, collaboration, and innovation.
Whether you are participating as a keynote speaker, oral presenter, poster contributor, exhibitor, or delegate, we encourage you to engage actively in discussions, share expertise, and build collaborations that will advance patient care and metabolic research.
We look forward to welcoming you to Paris for an enriching, inspiring, and memorable scientific experience.
Warm regards,
Organizing Committee
20th World Congress on Endocrinology and Diabetes
About Conference
The 20th World Congress on Endocrinology and Diabetes will take place on September 29–30, 2026, in Paris, France, bringing together a distinguished gathering of global leaders, scientists, clinicians, academicians, and industry partners. The conference aims to address the most pressing challenges facing endocrinology and diabetes care through robust scientific discussions, knowledge exchange, and collaborative initiatives.
This year’s congress will highlight advancements across endocrinology—including hormone disorders, metabolic syndrome, reproductive endocrinology, thyroid disease, adrenal pathologies, obesity science, and diabetes innovation. The scientific program features keynote talks, symposiums, interactive workshops, oral and poster sessions, case discussions, and industry-led showcases.
With an emphasis on precision medicine, digital health, AI-powered diagnostics, cutting-edge therapeutics, and real-world clinical solutions, the congress provides a comprehensive platform for attendees across academia, clinical practice, and industry.
CONFERENCE AGENDA
Registration & Kit Collection: Participants will begin with registration, badge pick-up, kit distribution, and program schedules. On-site support staff will assist with queries.
Opening Ceremony & Keynote Speeches: The event commences with a welcome address from the organizing committee followed by inaugural keynote lectures delivered by prominent endocrinologists and diabetes experts. A group photograph concludes the session.
Scientific Sessions & Abstract Presentations: Multiple parallel tracks will cover diabetes management, endocrine disorders, metabolic research, obesity therapeutics, hormone regulation, reproductive endocrinology, and digital health. Oral, poster, and virtual sessions provide opportunities for scientific dissemination.
Networking & Poster Interactions: Coffee and tea breaks create opportunities for discussions, poster viewing, collaboration, and one-on-one scientific exchange.
Conference Lunch & Award Ceremony: Participants enjoy networking lunches and, on the final day, an award program recognizing outstanding oral and poster presentations, followed by closing remarks.
Optional Social Activities: Guided city tours, networking dinners, and cultural activities are available for participants wishing to explore the heritage and beauty of Paris.
Why to Attend?
Attending the 20th World Congress on Endocrinology & Diabetes offers unparalleled advantages:
-
Gain insights into cutting-edge advances in diabetes management, endocrine disorders, metabolic science, obesity therapeutics, reproductive health, and precision medicine.
-
Learn from global experts leading groundbreaking research, clinical guidelines, and technology-driven solutions in endocrinology.
-
Build lasting professional networks with clinicians, researchers, industry representatives, academicians, and policymakers from over 40 countries.
-
Present your research to a global audience to enhance academic visibility and professional credibility.
-
Explore emerging themes such as AI-assisted diabetic diagnostics, digital metabolic health tools, insulin innovations, wearable monitoring, hormone replacement advancements, and targeted metabolic therapies.
-
Participate in interactive workshops designed to translate clinical evidence into effective practice.
Experience Paris—its science, culture, cuisine, and timeless architecture—while engaging in high-level scientific exchange.
Participation and Presentation Options
To support diverse global participants, the 2026 Congress offers multiple presentation formats:
Oral Presentation: Present full research studies, clinical outcomes, analytical discoveries, innovative diagnostics, or therapeutic advancements in endocrinology and diabetes. Engage with experts through Q&A sessions.
Poster Presentation: Ideal for preliminary findings, methodological advances, case studies, or ongoing projects. Dedicated poster walks encourage scientific dialogue and feedback.
Virtual Presentation: Designed for those unable to travel. Receive equal recognition, certificates, and program inclusion.
Delegate Participation: Attend all scientific sessions, workshops, and panels without presenting.
Exhibitor & Sponsorship Opportunities: Perfect for biotechnology companies, diagnostics firms, startups, pharmaceutical industries, academic institutions, and medical device firms. Showcase innovative products, tools, and technologies to a global audience.
PARTICIPATION AND PRESENTATION OPTIONS:
Knowledge Enhancement & Skill Development
-
Learn from leading endocrinologists, diabetologists, metabolic scientists, and digital health innovators.
-
Gain exposure to breakthrough research in insulin analogs, glucose monitoring technologies, endocrine biomarkers, metabolic genetics, reproductive endocrinology, and obesity therapeutics.
-
Participate in workshops on clinical best practices, AI-driven diagnostics, multi-omics metabolic profiling, and innovative treatment frameworks.
Global Networking Opportunities
-
Meet professionals from more than 40 countries.
-
Build collaborations for joint research, publications, funding, and institutional partnerships.
-
Connect with mentors, peers, and industry leaders shaping the future of metabolic health.
Presentation & Publication Advantages
Selected abstracts may be featured in conference proceedings or partner publications. Early submissions receive priority scheduling and enhanced visibility.
Career Growth & Development
Diverse Scientific Formats
Enjoy access to:
Post-Conference Resources
Participants receive:
Visa Assistance & Flexible Participation
Institutional Benefits
Institutions gain:
Cultural & Experiential Value
On-site delegates can:
-
Explore Paris
-
Join social dinners and city tours
-
Experience international cultural exchange
Certification & Recognition
All participants receive:
-
Certificate of Participation
-
Certificate of Presentation (for presenters)
-
Official endorsement from the 20th World Congress on Endocrinology & Diabetes
Abstract Review Process
Our structured and transparent abstract evaluation ensures quality and relevance:
Submission: Abstracts are submitted through the official online portal.
Pre-Screening: Editors check relevance, format, and clarity.
Double-Blind Peer Review: Evaluated by two independent experts in endocrinology, diabetes, or related specialties.
Scoring Criteria:
-
Scientific merit and originality
-
Methodological soundness
-
Clinical relevance
-
Alignment with conference themes
Decision & Notification: Authors receive acceptance confirmation for Oral, Poster, or Virtual format.
Early Submission Advantage: Early abstracts receive preferred presentation slots and enhanced program visibility.
VISA Process
We assist all international participants in securing their travel visas.
After confirming registration, participants receive:
General Visa Requirements:
Applicants may need:
Participants are encouraged to apply 6–8 weeks in advance.
Visa Rejection Support:
In the event of a visa refusal:
-
Participants may switch to Virtual Presentation/Participation with no deduction.
-
Refunds are possible upon submission of an official refusal letter.
-
Refunds processed within 2–3 weeks.
-
Registration can also be transferred to the next edition.
Market Analysis
The global endocrinology and diabetes landscape is expanding rapidly due to rising disease prevalence, technological advancements, and growing demand for personalized care.
-
The global diabetes care market is projected to exceed USD 100 billion by 2030, driven by insulin innovations, glucose monitoring systems, and digital health tools.
-
Continuous glucose monitoring (CGM) and insulin pump technologies show strong annual growth, largely due to improved accuracy and patient adoption.
-
The endocrine disorder therapeutics market continues to grow steadily, driven by thyroid, adrenal, and reproductive hormone therapies.
-
Obesity therapeutics, including GLP-1 receptor agonists and metabolic agents, represent one of the fastest-growing global health markets.
-
Advances in AI-based diagnostics, tele-endocrinology, wearable metabolic monitors, and personalized hormone therapies are reshaping global patient care.
-
Increased investment in genomics, metabolic research, and digital health ecosystems offers new opportunities for scientific and industrial collaborations.
The congress provides a vital platform for researchers, clinicians, and industry leaders to align with evolving market trends and contribute to the future of endocrinology and diabetes innovation.
